NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









EndoShunt Medical Inc.

EndoShunt Medical Inc.

Private
Nashville, TennesseeHealthcare & Life Scienceshttps://endoshunt.com/

Last Round

Series A

Oct 22, 2025

Total Funding Raised

$9.01M

Company Overview

EndoShunt Medical Inc. is a medical device company that develops endovascular solutions for the rapid, targeted control of abdominal hemorrhage in trauma patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

endovascular devicehemorrhage controltrauma surgerymedical deviceaortic occlusionREBOAminimally invasive surgerysurgical hardwarecritical carevascular surgeryemergency medicinebleeding controltrauma caremedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EndoShunt Medical Inc. Comparables

Compare EndoShunt Medical Inc. with similar companies based on industry and business-model similarity.

EndoShunt Medical Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Emergency Scientific
88%
Front Line Medical Technologies
87%
Prytime Medical Devices, Inc.
85%

EndoShunt Medical Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 22, 2025
GrantMay 1, 2024
Pre SeedDec 1, 2023
GrantApr 25, 2022

Key People

Founding team and executive leadership

Tyler Zanon

Chief Executive Officer

Executive Team

EndoShunt Medical Inc. Investors

Notable investors and investment history

EndoShunt Medical Inc. investors
InvestorRounds
Octerra CapitalPre Seed
New York AngelsSeries A
NSF I-Corps ProgramGrant
Harvard President's Innovation ChallengeGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 1, 2023

    $381K raised from Octerra Capital and Allston Venture Fund.

EndoShunt Medical Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EndoShunt Medical Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EndoShunt Medical Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNashville, Tennessee
Employee Range5
Year FoundedN/A
Last FundingOct 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.